We are live on ! Find out more
VNRX icon

VolitionRx Ltd

33 hedge funds and large institutions have $17.7M invested in VolitionRx Ltd in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 4

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

14% more funds holding

Funds holding: 2933 (+4)

0.05% more ownership

Funds ownership: 1.16%1.21% (+0.05%)

3% less capital invested

Capital invested by funds: $18.2M → $17.7M (-$498K)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
33
Holders Change
+4
Holders Change %
+13.79%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
7
Increased
13
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$543
Fidelity Investments
27
Fidelity Investments
Massachusetts
$475 +$466 +35 New
Osaic Holdings
28
Osaic Holdings
Arizona
$292 +$293 +22 New
Citigroup
29
Citigroup
New York
$236 +$226 +17 New
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$180
AF
31
Allworth Financial
California
$136
SS
32
SBI Securities
Japan
$79 +$13 +1 +20%
Squarepoint
33
Squarepoint
New York
-$44.2K -2,910 Closed
William Blair & Company
34
William Blair & Company
Illinois
-$30.4K -2,000 Closed
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
-$12.7K -833 Closed
Simplex Trading
36
Simplex Trading
Illinois
-$266 -20 -63%

VNRX Hedge Fund Activity: Q3 2025 in Review

33 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2025, worth a combined $17.7M — down 2.7% from $18.2M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new VNRX positions and 3 closed out — a net gain of 4 holders — while 13 added to existing stakes and 4 trimmed.

The largest buyer was Armistice Capital, adding an estimated $590K. The largest seller was Vanguard Group, cutting an estimated $63K.

  • 33 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2025, up from 29 in Q2 2025.
  • Funds reported $17.7M of VolitionRx Ltd stock for Q3 2025, down 2.7% quarter-over-quarter.
  • 7 funds opened new VolitionRx Ltd positions in Q3 2025 and 3 closed out, a net change of +4 holders.
  • The largest VolitionRx Ltd buyer in Q3 2025 was Armistice Capital, an estimated $590K added.
  • The largest VolitionRx Ltd seller in Q3 2025 was Vanguard Group, an estimated $63K sold.

Based on aggregated 13F filings for Q3 2025.